Kinetics and efficacy of an organophosphorus hydrolase in a rodent model of methyl-parathion poisoning.

Publisher: Wiley Country of Publication: United States NLM ID: 9418450 Publication Model: Print Cited Medium: Internet ISSN: 1553-2712 (Electronic) Linking ISSN: 10696563 NLM ISO Abbreviation: Acad Emerg Med Subsets: MEDLINE

Publication: Hoboken, N.J. : Wiley
Original Publication: Philadelphia, PA : Hanley & Belfus, c1993-

Aryldialkylphosphatase/*pharmacokinetics ; Methyl Parathion/*poisoning; Animals ; Aryldialkylphosphatase/pharmacology ; Disease Models, Animal ; Half-Life ; Lethal Dose 50 ; Rats ; Rats, Wistar

Objectives: Organophosphorus (OP) pesticides exert a tremendous health burden, particularly in the developing world. Limited resources, the severity of intentional OP ingestions, and a paucity of beneficial therapies all contribute to the morbidity and mortality of this broad class of chemicals. A novel theoretical treatment for OP poisoning is the use of an enzyme to degrade the parent OP in the circulation after poisoning. The aims of this study were to determine the pharmacokinetics and efficacy of an OP hydrolase (OpdA) in a rodent model of severe methyl-parathion poisoning.
Methods: Two animal models were used. First, Wistar rats were administered two different doses of the hydrolase (0.15 and 1.5 mg/kg), and the ex vivo hydrolytic activity of plasma was determined by a fluorometric method. Second, an oral methyl-parathion animal poisoning model was developed to mimic severe human poisoning, and the efficacy of postpoisoning OpdA (as measured by survival to 4 and 24 hours) was determined.
Results: The half-life of OpdA in the Wistar rat was dependent on the dose administered and ranged between 45.0 and 57.9 minutes. The poisoning model of three times the lethal dose to 50% of the population (3 x LD(50)) of methyl-parathion resulted in 88% lethality at 4 and 24 hours. Using a single dose of 0.15 mg/kg OpdA 10 minutes after poisoning resulted in 100% survival at 4 hours (p = 0.001 vs. placebo), but 0% at 24 hours postpoisoning (p = NS vs. placebo).
Conclusions: The OP hydrolase OpdA exhibits pharmacokinetics suitable for repeated dosing and increases short-term survival after severe methyl-parathion poisoning.
(2010 by the Society for Academic Emergency Medicine)

Protein Eng. 2003 Feb;16(2):135-45. (PMID: 12676982)
Appl Environ Microbiol. 2009 Aug;75(15):5153-6. (PMID: 19502439)
Appl Environ Microbiol. 2002 Jul;68(7):3371-6. (PMID: 12089017)
Front Biosci (Schol Ed). 2010 Jan 01;2:209-20. (PMID: 20036941)
Crit Rev Toxicol. 1999 Jan;29(1):21-57. (PMID: 10066159)
Toxicology. 2001 Sep 25;166(3):139-60. (PMID: 11543910)
Toxicol Rev. 2003;22(3):143-63. (PMID: 15181664)
Lett Appl Microbiol. 2002;34(4):263-8. (PMID: 11940156)
J Hazard Mater. 2008 Sep 15;157(2-3):308-14. (PMID: 18258361)
J Appl Toxicol. 1994 Mar-Apr;14(2):111-3. (PMID: 8027505)
Curr Opin Microbiol. 2002 Jun;5(3):288-95. (PMID: 12057683)
Clin Evid. 2005 Jun;(13):1744-55. (PMID: 16135310)
World Health Stat Q. 1990;43(3):139-44. (PMID: 2238694)
Chem Biol Interact. 2005 Dec 15;157-158:345-7. (PMID: 16263103)
Clin Exp Pharmacol Physiol. 2004 Nov;31(11):817-21. (PMID: 15566400)
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21631-6. (PMID: 19966226)
Toxicol Lett. 2002 Mar 10;128(1-3):215-28. (PMID: 11869832)
Acad Emerg Med. 2003 Apr;10(4):295-8. (PMID: 12670839)
QJM. 2008 Jun;101(6):467-74. (PMID: 18375477)
Toxicol Lett. 2004 Jun 15;151(1):219-33. (PMID: 15177657)

R21 ES014019 United States ES NIEHS NIH HHS; R21 ES014019-01A2 United States ES NIEHS NIH HHS

41BCL2O91D (Methyl Parathion)
EC 3.1.8.1 (Aryldialkylphosphatase)

Date Created: 20100727 Date Completed: 20101208 Latest Revision: 20211020

20240829

PMC2911639

10.1111/j.1553-2712.2010.00798.x

20653588